Peter Michael Schlag

Title: Peter Michael Schlag: Innovator in Cancer Treatment

Introduction

Peter Michael Schlag is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer treatment, holding a total of 5 patents. His work focuses on innovative methods to combat cancer metastasis, showcasing his dedication to advancing medical science.

Latest Patents

One of his latest patents involves the use of niclosamide for the treatment of cancer metastasis. This method includes identifying a subject in need of treatment by assessing elevated levels of S100A4 transcription. The administration of niclosamide or its derivatives is aimed at inhibiting or reducing the risk of cancer metastasis, with specific dosage guidelines provided. Another significant patent relates to a DNA expression construct designed for cancer treatment. This construct features a dumbbell-shaped circular strand of DNA, which is intended to be administered via jet injection, enhancing the effectiveness of cancer therapies.

Career Highlights

Throughout his career, Peter Michael Schlag has worked with prominent organizations such as Mologen AG and the Max Delbrück Center for Molecular Medicine in Berlin-Buch. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Peter has collaborated with esteemed colleagues, including Wolfgang Walther and Ulrike Stein. Their combined expertise has contributed to the advancement of innovative cancer treatment methodologies.

Conclusion

Peter Michael Schlag's contributions to cancer treatment through his patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in cancer therapies and improve patient outcomes.